The Relationship of Serum Uric Acid With Neurocognitive Functions in Children and Adolescents With Mild to Moderate

Stephen R Hooper1, Jennifer Roem2, Michael F Schneider2

  • 1Department of Health Sciences, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Pediatric Neurology
|January 23, 2026
PubMed

Insights

This study found no clear link between serum uric acid (SUA) levels and neurocognitive function in children with chronic kidney disease (CKD). However, higher SUA may offer some protection against cognitive dysfunction.

Area of Science:

  • Pediatric Nephrology
  • Neuropsychology
  • Chronic Kidney Disease Research

Background:

  • Pediatric chronic kidney disease (CKD) impacts children's neurocognitive function, even in mild cases.
  • Mechanisms behind neurocognitive disruption in pediatric CKD remain unclear.
  • Serum uric acid (SUA) affects adult neurocognition in CKD, but its role in children is understudied.

Purpose of the Study:

  • Investigate the association between serum uric acid (SUA) levels and neurocognitive function in children with mild to moderate CKD.
  • Examine the relationship between changes in SUA levels and neurocognitive outcomes.
  • Address a gap in understanding SUA's impact on pediatric neurocognition.

Main Methods:

  • Utilized data from 593 participants in the North American Chronic Kidney Disease in Children study.
  • Assessed neurocognition through IQ, problem-solving, selective attention, and working memory tests.
  • Included parent ratings of executive functions for comprehensive evaluation.

Main Results:

  • No consistent associations were found between SUA levels (current or changing) and neurocognitive outcomes after statistical adjustment.
  • Medium to high SUA levels showed a potential neuroprotective effect, possibly reducing the risk of cognitive dysfunction.
  • Specific findings suggested a protective role for SUA in verbal and visual working memory, and attention regulation.

Conclusions:

  • This study, among the first to explore SUA and neurocognition in pediatric CKD, found no clear associations.
  • The results suggest a complex relationship, with potential neuroprotective roles for SUA at higher levels.
  • Further research is needed to fully elucidate the role of SUA in neurocognitive outcomes in pediatric CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
612
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
598
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
373
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
338
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
390